华润医药(03320)：华润双鹤上半年归母净利为约9.75亿元，同比减少6.79%

Group 1 - The core viewpoint of the article is that China Resources Pharmaceutical (03320) reported a decline in its mid-year performance for 2025, with total revenue approximately 5.7415 billion yuan, a year-on-year decrease of 3.16% [1] - The net profit attributable to shareholders of the listed company is approximately 975 million yuan, reflecting a year-on-year decrease of 6.79% [1] - The basic earnings per share are reported at 0.9480 yuan, with a cash dividend distribution of 1 yuan per 10 shares (including tax) [1]